Position in GERN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,057,556
+$113,641 QoQ
Shares Held
826,216
+30.4% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 258 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Derivatives in GERN
reported options exposure · as of Dec 31, 2020CallValue
$34,503
CallShares
21,700
PutValue
$16,218
PutShares
10,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. GERN ranks #143 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in GERN
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,057,556 | 826,216 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $943,915 | 633,501 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $183,995 | 139,391 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $104,545 | 76,312 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $562,272 | 398,775 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,781,320 | 1,120,328 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,542,126 | 1,000,601 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,968,302 | 433,547 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $971,044 | 229,020 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $7,098,204 | 2,150,971 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,502,211 | 711,949 | Shares | Defined | 2024-02-09 | |
| 2023-06-30 | $1,699,177 | 529,339 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $3,213,127 | 1,480,704 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,379,416 | 570,007 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $1,207,926 | 516,208 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $589,554 | 380,358 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $218,679 | 160,794 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $632,128 | 518,138 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $407,166 | 297,202 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $1,013,866 | 719,054 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $1,544,954 | 977,819 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $34,503 | 21,700 | Call | Defined | 2021-02-11 | |
| 2020-12-31 | $136,142 | 85,624 | Shares | Defined | 2021-02-11 | |
| 2020-12-31 | $16,218 | 10,200 | Put | Defined | 2021-02-11 | |
| 2020-09-30 | $37,758 | 21,700 | Call | Defined | 2020-11-12 | |
| 2020-09-30 | $251,203 | 144,370 | Shares | Defined | 2020-11-12 | |
| 2020-09-30 | $17,748 | 10,200 | Put | Defined | 2020-11-12 | |
| 2020-06-30 | $22,236 | 10,200 | Put | Defined | 2020-08-12 | |
| 2020-06-30 | $47,306 | 21,700 | Call | Defined | 2020-08-12 | |
| 2020-06-30 | $251,859 | 115,532 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $106,290 | 89,320 | Shares | Defined | 2020-05-12 | |
| 2020-03-31 | $12,138 | 10,200 | Put | Defined | 2020-05-12 | |
| 2020-03-31 | $25,823 | 21,700 | Call | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||